New Doctrine of the French National Authority for Health

In line with its Action Plan for Innovative Medicines outlined in early 2020, the French National Authority for Health has updated its doctrine for the health technology assessment of medicines.

Following its Action Plan for Innovative Medicines and its clarification of the health technology assessment of therapeutic value (Service médical rendu – “SMR”) conditionality, the Transparency Commission of the French National Authority for Health (Commission de la Transparence de la Haute Autorité de santé) completed the year 2020 by publishing its new doctrine on the health technology assessment of medicines for access to reimbursement.

This updated doctrine specifies the procedures for the reassessment of the therapeutic value and of the improvement in medical service rendered (Amélioration du service médical rendu – “ASMR”) on the basis of the post-registration studies and additional data that it will have previously required pursuant to the regulatory provisions introduced by the market access decree of August 25, 2020.

The French National Authority for Health is also developing its doctrine on "targeted therapies" (thérapies ciblées) by providing the methodology applicable to "basket" trials in oncology, and in particular its expectations in terms of comparison.

 

 

Authored by Charlotte Damiano

Contacts
Charlotte Damiano
Partner
Paris
Jean-Baptiste Chagnon
Associate
Paris

 

This website is operated by Hogan Lovells Solutions Limited, whose registered office is at 21 Holborn Viaduct, London, United Kingdom, EC1A 2DY. Hogan Lovells Solutions Limited is a wholly-owned subsidiary of Hogan Lovells International LLP but is not itself a law firm. For further details of Hogan Lovells Solutions Limited and the international legal practice that comprises Hogan Lovells International LLP, Hogan Lovells US LLP and their affiliated businesses ("Hogan Lovells"), please see our Legal Notices page. © 2021 Hogan Lovells.

Attorney advertising. Prior results do not guarantee a similar outcome.